Number of the records: 1  

Inhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperlipoproteinémiou

  1. Inhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperlipoproteinémiou = PCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia / Andrej Dukát ... [et al.]. -- ilustr., tab. -- Bibliogr. odkazy - Res. angl., slov.

    In Forum diabetologicum. -- Brno : Facta Medica, 2018. -- s. 1-80. -- ISSN 1805-3807. -- Roč. 7, č. 1 (2018), s. 71-75

    I. Dukát, Andrej, 1950-
    II. Kriška, Milan, 1940-
    III. Sabaka, Peter
    IV. Gavorník, Peter, 1948-2022
    V. Kužma, Martin
    VI. Payer, Juraj, 1958-
    VII. Forum diabetologicum. -- Roč. 7, č. 1 (2018), s. 71-75
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.